[Current aspects in surgical treatment of benign adrenal cystic lesions].
OBJECTIVE
To determine the safety and efficacy of retroperitoneal endoscopic adrenalectomy for benign cystic adrenal lesions.


METHODS
4 patients underwent retroperitoneal endoscopic adrenalectomy of benign cystic adrenal lesions at our center between March-September 2006.


RESULTS
Retroperitoneal endoscopic adrenalectomy was successfully performed in all patents, no conversion was needed. The mean operative time was 60 minutes (range 45-90 min) and no complications were observed. The average hospital stay was 2 days. Neither clinical, no US-scan recurrence was observed on the first month postoperativelly.


CONCLUSIONS
Retroperitoneal endoscopic adrenalectomy is a safe and efficacious procedure that offers a favorable minimally invasive alternative for the treatment of benign cystic adrenal lesions.
G
G
Todorov
R
R
Petkov
N
N
Iarŭmov
D000307:Adrenal Gland Diseases / Q000000981:diagnostic imaging / Q000601:surgery*; D000315:Adrenalectomy / Q000379:methods*; D000328:Adult; D003560:Cysts / Q000000981:diagnostic imaging / Q000601:surgery*; D004724:Endoscopy; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012187:Retroperitoneal Space / Q000000981:diagnostic imaging / Q000601:surgery; D016896:Treatment Outcome; D014463:Ultrasonography